196 related articles for article (PubMed ID: 23900502)
1. Elevated expression of cyclooxygenase-2 and microsomal prostaglandin E synthase-1 in primary sclerosing cholangitis: ιmplications for cholangiocarcinogenesis.
Ishii Y; Sasaki T; Serikawa M; Minami T; Okazaki A; Yukutake M; Ishigaki T; Kosaka K; Mouri T; Yoshimi S; Shimizu A; Tsuboi T; Chayama K
Int J Oncol; 2013 Oct; 43(4):1073-9. PubMed ID: 23900502
[TBL] [Abstract][Full Text] [Related]
2. Microsomal prostaglandin E synthase-1 inhibits PTEN and promotes experimental cholangiocarcinogenesis and tumor progression.
Lu D; Han C; Wu T
Gastroenterology; 2011 Jun; 140(7):2084-94. PubMed ID: 21354147
[TBL] [Abstract][Full Text] [Related]
3. PGE2 signaling and its biosynthesis-related enzymes in cholangiocarcinoma progression.
Jongthawin J; Chusorn P; Techasen A; Loilome W; Boonmars T; Thanan R; Puapairoj A; Khuntikeo N; Tassaneeyakul W; Yongvanit P; Namwat N
Tumour Biol; 2014 Aug; 35(8):8051-64. PubMed ID: 24839005
[TBL] [Abstract][Full Text] [Related]
4. Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma.
Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
Am J Surg Pathol; 2010 Jan; 34(1):27-34. PubMed ID: 19898228
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of coexpression of microsomal prostaglandin E synthase-1 and cyclooxygenase-2 in interleukin-1-stimulated equine articular chondrocytes.
Farley J; Sirois J; MacFarlane PH; Kombé A; Laverty S
Am J Vet Res; 2005 Nov; 66(11):1985-91. PubMed ID: 16334960
[TBL] [Abstract][Full Text] [Related]
6. Neoplastic Transformation of the Peribiliary Stem Cell Niche in Cholangiocarcinoma Arisen in Primary Sclerosing Cholangitis.
Carpino G; Cardinale V; Folseraas T; Overi D; Grzyb K; Costantini D; Berloco PB; Di Matteo S; Karlsen TH; Alvaro D; Gaudio E
Hepatology; 2019 Feb; 69(2):622-638. PubMed ID: 30102768
[TBL] [Abstract][Full Text] [Related]
7. Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma.
Wu X; Xia M; Chen D; Wu F; Lv Z; Zhan Q; Jiao Y; Wang W; Chen G; An F
Tumour Biol; 2016 Nov; 37(11):15019-15029. PubMed ID: 27658773
[TBL] [Abstract][Full Text] [Related]
8. Inducible prostaglandin E synthase is overexpressed in non-small cell lung cancer.
Yoshimatsu K; Altorki NK; Golijanin D; Zhang F; Jakobsson PJ; Dannenberg AJ; Subbaramaiah K
Clin Cancer Res; 2001 Sep; 7(9):2669-74. PubMed ID: 11555578
[TBL] [Abstract][Full Text] [Related]
9. Elevated prostaglandin E2 level via cPLA2--COX-2--mPGES-1 pathway involved in bladder carcinogenesis induced by terephthalic acid-calculi in Wistar rats.
Shi Y; Cui L; Dai G; Chen J; Pan H; Song L; Cheng S; Wang X
Prostaglandins Leukot Essent Fatty Acids; 2006 May; 74(5):309-15. PubMed ID: 16621493
[TBL] [Abstract][Full Text] [Related]
10. Biliary dysplasia, cell proliferation and nuclear DNA-fragmentation in primary sclerosing cholangitis with and without cholangiocarcinoma.
Bergquist A; Glaumann H; Stål P; Wang GS; Broomé U
J Intern Med; 2001 Jan; 249(1):69-75. PubMed ID: 11168786
[TBL] [Abstract][Full Text] [Related]
11. Cholangiocarcinoma cell proliferation is enhanced in primary sclerosing cholangitis: A role for IL-17A.
Lieshout R; Kamp EJCA; Verstegen MMA; Doukas M; Dinjens WNM; Köten K; IJzermans JNM; Bruno MJ; Peppelenbosch MP; van der Laan LJW; de Vries AC
Int J Cancer; 2023 Jun; 152(12):2607-2614. PubMed ID: 36346104
[TBL] [Abstract][Full Text] [Related]
12. Regulation of prostaglandin E synthases: effects of siRNA-mediated inhibition of microsomal prostaglandin E synthase-1.
Båge T; Modéer T; Kawakami T; Quezada HC; Yucel-Lindberg T
Biochim Biophys Acta; 2007 Oct; 1773(10):1589-98. PubMed ID: 17707523
[TBL] [Abstract][Full Text] [Related]
13. Microsomal prostaglandin E synthase-1 is a major terminal synthase that is selectively up-regulated during cyclooxygenase-2-dependent prostaglandin E2 production in the rat adjuvant-induced arthritis model.
Claveau D; Sirinyan M; Guay J; Gordon R; Chan CC; Bureau Y; Riendeau D; Mancini JA
J Immunol; 2003 May; 170(9):4738-44. PubMed ID: 12707354
[TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase-2 and microsomal prostaglandin E synthase-1 are overexpressed in squamous cell carcinoma of the penis.
Golijanin D; Tan JY; Kazior A; Cohen EG; Russo P; Dalbagni G; Auborn KJ; Subbaramaiah K; Dannenberg AJ
Clin Cancer Res; 2004 Feb; 10(3):1024-31. PubMed ID: 14871981
[TBL] [Abstract][Full Text] [Related]
15. Inducible microsomal prostaglandin E synthase is overexpressed in colorectal adenomas and cancer.
Yoshimatsu K; Golijanin D; Paty PB; Soslow RA; Jakobsson PJ; DeLellis RA; Subbaramaiah K; Dannenberg AJ
Clin Cancer Res; 2001 Dec; 7(12):3971-6. PubMed ID: 11751489
[TBL] [Abstract][Full Text] [Related]
16. Expression of microsomal prostaglandin E synthase-1 in intestinal type gastric adenocarcinoma and in gastric cancer cell lines.
van Rees BP; Sivula A; Thorén S; Yokozaki H; Jakobsson PJ; Offerhaus GJ; Ristimäki A
Int J Cancer; 2003 Nov; 107(4):551-6. PubMed ID: 14520691
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin E2 synthesis in cartilage explants under compression: mPGES-1 is a mechanosensitive gene.
Gosset M; Berenbaum F; Levy A; Pigenet A; Thirion S; Saffar JL; Jacques C
Arthritis Res Ther; 2006; 8(4):R135. PubMed ID: 16872525
[TBL] [Abstract][Full Text] [Related]
18. Cholangiocytes in the pathogenesis of primary sclerosing cholangitis and development of cholangiocarcinoma.
Chung BK; Karlsen TH; Folseraas T
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1390-1400. PubMed ID: 28844951
[TBL] [Abstract][Full Text] [Related]
19. IL-1beta treatment does not co-ordinately up-regulate mPGES-1 and COX-2 mRNA expression, but results in higher degree of cellular and intracellular co-localization of their immunoreactive proteins in human placenta trophoblast cells.
Premyslova M; Chisaka H; Okamura K; Challis JR
Placenta; 2006; 27(6-7):576-86. PubMed ID: 16183115
[TBL] [Abstract][Full Text] [Related]
20. Necrosis in DU145 prostate cancer spheroids induces COX-2/mPGES-1-derived PGE2 to promote tumor growth and to inhibit T cell activation.
Sha W; Olesch C; Hanaka H; Rådmark O; Weigert A; Brüne B
Int J Cancer; 2013 Oct; 133(7):1578-88. PubMed ID: 23536473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
